Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I
Cardiovascular diseases (CVDs) are one of the foremost causes of mortality in intensive care units worldwide. The development of a rapid method to quantify cardiac troponin I (cTnI)—the gold-standard biomarker of myocardial infarction (MI) (or “heart attack”)—becomes crucial in the early diagnosis a...
Guardado en:
Autores principales: | Remya Radha, Mohammad Hussein Al-Sayah |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/499663c0eb4844afb9a147a6b59db920 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Homocysteine is associated with plasma high-sensitivity cardiac troponin T levels in a community-dwelling population
por: Cao R, et al.
Publicado: (2013) -
Troponina en el diagnóstico de infarto al miocardio: Consideraciones desde el laboratorio clínico
por: GUZMÁN D,ANA MARÍA, et al.
Publicado: (2010) -
The Effects of Allopurinol on Levels of Cardiac Troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial
por: Sajad Khiali, et al.
Publicado: (2021) -
Cardioprotective Effects of Curcumin-Nisin Based Poly Lactic Acid Nanoparticle on Myocardial Infarction in Guinea Pigs
por: Williams E. E. Nabofa, et al.
Publicado: (2018) -
Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 2
por: Aleksey M. Chaulin
Publicado: (2021)